Aerovent (Ipratropium Bromide) in Kenya

Overview

Aerovent is an anticholinergic bronchodilator containing ipratropium bromide, used to manage COPD (Chronic Obstructive Pulmonary Disease) and asthma. It relaxes airway muscles by blocking acetylcholine, improving breathing. Available as a metered-dose inhaler (MDI) in Kenya, it requires prescription and is often combined with short-acting beta-agonists (e.g., salbutamol) for synergistic effects.

Composition

• Active Ingredient: Ipratropium Bromide 20µg per actuation.
• Form: Metered-dose inhaler (MDI) with 200 doses.
• Propellant: HFA-134a (CFC-free).
• Inactive Ingredients: Ethanol, purified water, citric acid.

Side Effects

Common

• Dry Mouth/Throat: Due to anticholinergic effects.
• Cough, Headache: Mild and transient.
• Nausea, Dizziness: Especially in elderly patients.

Serious Risks

• Paradoxical Bronchospasm: Worsening wheezing (discontinue immediately).
• Glaucoma Precipitation: Acute angle-closure (avoid in predisposed patients).
• Urinary Retention: Risk in men with prostatic hyperplasia.
• Allergic Reactions: Rash, angioedema (rare).

How to Use

• Dosage:
  • COPD/Asthma: 1–2 puffs (40–80µg) 3–4 times daily.
  • Acute Bronchospasm: 2–4 puffs; repeat after 15 mins if needed.
• Administration:
  1. Shake Well: Before each use.
  2. Exhale Fully: Empty lungs before inhalation.
  3. Inhale Slowly: Press canister while breathing in deeply.
  4. Hold Breath: For 10 seconds.
  5. Rinse Mouth: Prevents dry mouth/thrush.
• Storage:
  • Store below 30°C; avoid direct sunlight/humidity.
  • Test spray before first use.

Frequently Asked Questions

1. Is Aerovent available over-the-counter in Kenya?
   No – prescription-only due to misuse risks.

2. How much does it cost?
   ~KES 800–1,500 per inhaler (200 doses). Generics (e.g., Ipravent) cost KES 600–1,000.

3. Does NHIF cover it?
   Partially – covered for COPD/asthma under chronic illness scheme (co-payment required).

4. Can it replace salbutamol inhalers?
   No – used adjunctively; salbutamol remains first-line for acute attacks.

5. Is it safe for children?
   Yes – but under pediatrician supervision (dose: 1–2 puffs 3x daily).

6. What if no improvement occurs?
   Recheck technique; consult doctor (may need steroid inhalers or combination therapy).

7. Are there Kenyan alternatives?
   Yes – Combivent (ipratropium + salbutamol) or generic ipratropium MDIs.

8. How long does one inhaler last?
   50–100 days (2–4 puffs/day).

Conclusion

Aerovent is a vital maintenance therapy for COPD and moderate-to-severe asthma in Kenya, offering bronchodilation without systemic side effects. While affordable and partially NHIF-covered, its prescription-only status ensures proper use. Critical for patients unresponsive to short-acting beta-agonists alone, it improves quality of life but requires strict adherence to dosing. In Kenya’s high-pollution areas (e.g., Nairobi, Mombasa), it mitigates exacerbations triggered by environmental irritants. Always combine with patient education on inhaler technique and regular follow-ups to optimize outcomes. For acute attacks, never use as monotherapy – always keep a rescue inhaler (e.g., salbutamol) accessible.